Reagan Jarvis

Company: Anocca
Job title: CEO
Seminars:
Engineered Cell Platforms For Profiling Off-Target TCR Allo- Reactivity And Cross-Reactivity 5:00 pm
Precise characterization of TCR off-target activity is critical to success of TCR-based cellular therapies Utilization of engineered cell platforms as analytical tools enables high-precision characterization of allo-reactivity and cross-reactivity phenomena Anocca’s assay technologies reveal fundamental insights into molecular basis of allo- and cross- reactivityRead more
day: Day One
Industry Leaders Fireside Chat – What Does the Future Hold for TCR therapies? 10:30 am
The hotly anticipated Industry Leader’s Fireside Chat will discuss the huge progress being made in the TCR therapeutic space. This session will explore the lessons we can takes from CAR-T, and will shed clarity on the priorities of the trailblazing companies in this field, whilst also touching upon the challenges faced with manufacturing costs, and…Read more
day: Day One